Search | WHO COVID-19 Research Database

mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study.

Kohli, Utkarsh; Desai, Lavina; Chowdhury, Devyani; Harahsheh, Ashraf S; Yonts, Alexandra B; Ansong, Annette; Sabati, Arash; Nguyen, Hoang H; Hussain, Tarique; Khan, Danyal; Parra, David A; Su, Jennifer A; Patel, Jyoti K; Ronai, Christina; Bohun, Monique; Freij, Bishara J; O'Connor, Matthew J; Rosanno, Joseph W; Gupta, Aamisha; Salavitabar, Arash; Dorfman, Adam L; Hansen, Jesse; Frosch, Olivia; Profita, Elizabeth L; Maskatia, Shiraz; Thacker, Deepika; Shrivastava, Shubhika; Harris, Tyler H; Feingold, Brian; Berger, Stuart; Campbell, Michael; Idriss, Salim F; Das, Srikant; Renno, Markus S; Knecht, Ken; Asaki, S Yukiko; Patel, Sunil; Ashwath, Ravi; Shih, Renata; Phillips, John; Das, Bibhuti; Ramachandran, Preeti; Sagiv, Eyal; Bhat, Aarti H; Johnson, Jonathan N; Taggart, Nathaniel W; Imundo, Jason; Nakra, Natasha; Behere, Shashank; Patel, Anjlee.

J Pediatr ; 243: 208-213.e3, 2022 04.

Article in English | MEDLINE | ID: covidwho-1587164

ABSTRACT

In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.

Subject(s)

COVID-19 , Myocarditis , Adolescent , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Humans , Myocarditis/epidemiology , Myocarditis/etiology , RNA, Messenger

Variable Presentation of COVID-19 in Pediatric Patients.

Crawford, Richard L; Bolin, Elijah H; Prodhan, Parthak; Renno, Markus S; Knecht, Kenneth R.

Pediatr Infect Dis J ; 40(2): e88-e90, 2021 02 01.

Article in English | MEDLINE | ID: covidwho-1061313

ABSTRACT

Infection by SARS-CoV-2 has led to disease referred to as coronavirus disease 2019 which, in children has been described as of multisystem inflammatory syndrome in children. Our experience demonstrates 2 distinct presentations of this syndrome which have different clinical courses and may have differing long-term outcomes.

Subject(s)

COVID-19/diagnosis , COVID-19/therapy , Systemic Inflammatory Response Syndrome/diagnosis , Systemic Inflammatory Response Syndrome/therapy , Adolescent , Biomarkers/analysis , COVID-19/pathology , Child , Child, Preschool , Hospitalization , Humans , Male , SARS-CoV-2 , Severity of Illness Index , Systemic Inflammatory Response Syndrome/pathology

ABSTRACT

Subject(s)

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL